Matrix Metalloproteinases: New Routes to the Use of MT1-MMP As A Therapeutic Target in Angiogenesis-Related Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|17|1787-1802

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.17, 2007-06, pp. : 1787-1802

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Matrix Metalloproteinases: A Therapeutic Target in Cardiovascular Disease

By  

Current Pharmaceutical Design, Vol. 9, Iss. 13, 2003-05 ,pp. : 1033-1040

Bentham Science Publishers

Access to resources Recommend Favorite

Matrix Metalloproteinases in Coronary Artery Disease:Clinical and Therapeutic Implications and Pathological Significance

By  

Current Medicinal Chemistry, Vol. 12, Iss. 8, 2005-04 ,pp. : 917-925

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Therapeutic Approaches Targeting Matrix Metalloproteinases in Cardiovascular Disease

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 10, 2012-05 ,pp. : 1214-1221

Bentham Science Publishers

Access to resources Recommend Favorite

Joint Diseases and Matrix Metalloproteinases: A Role for MMP-13

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 1, 2008-02 ,pp. : 47-54

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis as a therapeutic target in cancer

By Kumaran Gireesh   Clamp Andrew R   Jayson Gordon C  

Clinical Medicine, Vol. 8, Iss. 4, 2008-08 ,pp. : 455-458

Royal College Of Physicians

Access to resources Recommend Favorite